Related Experiment Video
Updated: Feb 13, 2026
05:56
Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
2.1K
Chronic nausea and vomiting: evaluation and treatment.
Brian E Lacy1, Henry P Parkman1, Michael Camilleri1
1Mayo Clinic, Jacksonville, FL, USA. Temple University, Philadelphia, PA, USA. Mayo Clinic, Rochester, MN, USA.
The American Journal of Gastroenterology
|March 17, 2018
Summary
Chronic nausea and vomiting (CNV) are complex conditions lasting over four weeks, stemming from various gastrointestinal and non-gastrointestinal issues. Effective management requires careful evaluation and personalized treatment strategies.
Area of Science:
- Gastroenterology
- Internal Medicine
Background:
- Chronic nausea and vomiting (CNV) are defined as symptoms lasting 4 weeks or more.
- These conditions arise from diverse gastrointestinal and non-gastrointestinal pathophysiological processes.
- The economic and quality-of-life impacts of CNV are significant, though prevalence data are limited.
Purpose of the Study:
- To review the evaluation and treatment of patients experiencing chronic nausea and vomiting.
- To emphasize common gastrointestinal causes of CNV.
Main Methods:
- Initial diagnostic evaluation distinguishes between gastrointestinal and non-gastrointestinal etiologies.
- Gastrointestinal causes are categorized based on gastric emptying studies (delayed vs. normal).
- Exclusion of anatomic, mechanical, and biochemical factors is crucial.
Main Results:
- Gastroparesis and cyclic vomiting syndrome are examples of specific GI conditions contributing to CNV.
- Non-gastrointestinal causes include medications, vestibular, and neurologic disorders.
- A validated treatment algorithm for CNV is currently lacking.
Conclusions:
- Treatment for CNV should be individualized, considering benefits, side effects, and costs.
- Comprehensive evaluation is key to identifying the underlying cause of chronic nausea and vomiting.
- Further research may lead to standardized treatment protocols for CNV.
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
798
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
798
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
708
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
708
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
923
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
923
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
641
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
641
01:22Pathophysiology of Vomiting
3.2K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
3.2K
01:23Chronic Pharyngitis
12.4K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
12.4K